BO
Boule Diagnostics AB
BOUL.ST · STO
3.22 kr +5.23% (+0.16 kr)
1M -9.55%
Market Cap 118.8M kr
P/E Ratio -
Div. Yield -
ROE 2.23%
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap P/S 0.26x
P/B 0.68x
P/FCF 6.83x
Growth
2 /100
Declining Book val. growth 28.71%
Rev. growth 3.69%
FCF growth N/A
Profitability
32 /100
Weak Net margin 0.82%
Op. margin 4.79%
FCF margin 3.77%
Quality
12 /100
Poor ROE 2.23%
ROA 0.79%
Asset turnover 0.96x
Debt
22 /100
High Current ratio 1.07x
Int. coverage 1.28x
Net debt/EBITDA 5.80x
Stability
30 /100
Unstable Rev. volatility 8.35%
EPS volatility 617.64%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BOUL.ST
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Johan Folkunger
Employees
200
Headquarters
Spånga
Evenimente viitoare
23 OCT.
Earnings
Upcoming earnings report